Knight Therapeutics Announces Regulatory Submission for : vi

MONTREAL, Oct. 06, 2022 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc., (TSX: GUD) ("Knight") a pan-American (ex-USA) specialty pharmaceutical company,...

Related Keywords

Montreal , Quebec , Canada , United States , United Kingdom , Brazil , America , Brazilian , American , Samira Sakhia , Morphosys Incyte , Biotoscana Farma , United Medical Ltd , Knight Therapeutics Inc , Xencor Inc , Drug Administration , Therapeutics Inc , Chief Executive Officer , Latin America , Antibody Dependent Cell Mediated Cytotoxicity , Antibody Dependent Cellular Phagocytosis , Region Europe , Latin American , United Medical , Toronto Stock Exchange Gud , Knight Therapeutics ,